Pharma Pulse 7/22/24: Global Diabetes & Obesity Therapeutics Study, Is There a Correlation Between Medical Debt and Delayed Mental Health Care? & more

Is There a Correlation Between Medical Debt and Delayed Mental Health Care in the United States?

JAMA study aims to determine whether financial barriers impact access to mental health services.

GoodRx to Offer Boehringer Ingelheim’s Humira Biosimilar

Boehringer Ingelheim’s high- and low-concentration adalimumab-adbm will be available through GoodRx for $550 for two-pack, which represents a 92% discount from the Humira list price.

J.D. Vance’s A.I. Agenda: Reduce Regulation

Donald Trump’s vice-presidential pick has indicated he favors a hands-off approach to A.I. but also wants to increase scrutiny of the biggest tech firms in the field.

Global Diabetes and Obesity Therapeutics, 2024 2028: Lucrative Market Opportunities with GLP-1-based Multi-agonists with Improved Tolerability Profile - ResearchAndMarkets.com

The "Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028" report has been added to ResearchAndMarkets.com's offering.

This study aims to identify the primary growth opportunities that will drive the diabesity market in the near future. The study also aims to highlight the most prominent and emerging business models prevalent across the market that will enable industry stakeholders to enhance their geographic coverage in terms of patient outreach and address the challenges of limited patient access.

@fda on Threads

Ugly veggies and fruits are just as tasty 😋 and nutritious!Toss them on the grill this summer and enjoy.

Learn more ways to reduce food waste: fda.gov/food…

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs